Annual Shareholders Equity
$26.53 M
+$183.60 M+116.89%
December 31, 2023
Summary
- As of February 8, 2025, CARM annual stockholders equity is $26.53 million, with the most recent change of +$183.60 million (+116.89%) on December 31, 2023.
- During the last 3 years, CARM annual shareholders equity has fallen by -$9.22 million (-25.80%).
- CARM annual shareholders equity is now -25.80% below its all-time high of $35.76 million, reached on December 1, 2020.
Performance
CARM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$11.13 M
-$11.49 M-3190.56%
September 30, 2024
Summary
- As of February 8, 2025, CARM quarterly stockholders equity is -$11.13 million, with the most recent change of -$11.49 million (-3190.56%) on September 30, 2024.
- Over the past year, CARM quarterly shareholders equity has dropped by -$57.42 million (-124.03%).
- CARM quarterly shareholders equity is now -112.93% below its all-time high of $86.07 million, reached on March 31, 2023.
Performance
CARM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CARM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +116.9% | -124.0% |
| 3 y3 years | -25.8% | +92.9% |
| 5 y5 years | -25.8% | +92.9% |
CARM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +116.9% | -112.9% | +92.9% |
| 5 y | 5-year | -25.8% | +116.9% | -112.9% | +92.9% |
| alltime | all time | -25.8% | +116.9% | -112.9% | +92.9% |
Carisma Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$11.13 M(-3190.6%) |
| Jun 2024 | - | $360.00 K(-96.7%) |
| Mar 2024 | - | $10.89 M(-58.9%) |
| Dec 2023 | $26.53 M | $26.53 M(-42.7%) |
| Sep 2023 | - | $46.30 M(-30.6%) |
| Jun 2023 | - | $66.70 M(-22.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $86.07 M(-154.8%) |
| Dec 2022 | -$157.06 M(-1450.6%) | -$157.06 M(+977.2%) |
| Jun 2022 | - | -$14.58 M(-225.4%) |
| Dec 2021 | $11.63 M(-67.5%) | - |
| Dec 2021 | - | $11.63 M |
| Dec 2020 | $35.76 M | - |
FAQ
- What is Carisma Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Carisma Therapeutics?
- What is Carisma Therapeutics annual shareholders equity year-on-year change?
- What is Carisma Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Carisma Therapeutics?
- What is Carisma Therapeutics quarterly shareholders equity year-on-year change?
What is Carisma Therapeutics annual stockholders equity?
The current annual shareholders equity of CARM is $26.53 M
What is the all time high annual shareholders equity for Carisma Therapeutics?
Carisma Therapeutics all-time high annual stockholders equity is $35.76 M
What is Carisma Therapeutics annual shareholders equity year-on-year change?
Over the past year, CARM annual stockholders equity has changed by +$183.60 M (+116.89%)
What is Carisma Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CARM is -$11.13 M
What is the all time high quarterly shareholders equity for Carisma Therapeutics?
Carisma Therapeutics all-time high quarterly stockholders equity is $86.07 M
What is Carisma Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CARM quarterly stockholders equity has changed by -$57.42 M (-124.03%)